A citation-based method for searching scientific literature

Eileen Rakovitch, Rinku Sutradhar, Nafisha Lalani, Sharon Nofech-Mozes, Sumei Gu, Mira Goldberg, Wedad Hanna, Cindy Fong, Lawrence Paszat. Breast Cancer Res Treat 2019
Times Cited: 6







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Victoria Sopik, Ping Sun, Steven A Narod. Breast Cancer Res Treat 2018
42
50

Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.
Cristina C Vieira, Cecilia L Mercado, Joan F Cangiarella, Linda Moy, Hildegard K Toth, Amber A Guth. Eur J Radiol 2010
46
50

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
457
50

Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
Lamis Shatat, Nika Gloyeske, Rashna Madan, Maura O'Neil, Ossama Tawfik, Fang Fan. Hum Pathol 2013
28
50

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.
Wei Zhang, Er-li Gao, Yi-li Zhou, Qi Zhai, Zhang-yong Zou, Gui-long Guo, Guo-rong Chen, Hua-min Zheng, Guan-li Huang, Xiao-hua Zhang. World J Surg Oncol 2012
21
33

Microinvasive breast carcinoma: An analysis from ten Senonetwork Italia breast centres.
Leopoldo Costarelli, Ettore Cianchetti, Fabio Corsi, Daniele Friedman, Matteo Ghilli, MariaTeresa Lacaria, Lorenzo Menghini, Roberto Murgo, Antonio Ponti, Stefano Rinaldi,[...]. Eur J Surg Oncol 2019
14
33

Predictors of microinvasion and its prognostic role in ductal carcinoma in situ.
Gloria R Sue, Donald R Lannin, Brigid Killelea, Anees B Chagpar. Am J Surg 2013
23
33

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
Isabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Isabelle Soubeyran, Véronique Picot, Jean-Michel Coindre. Cancer 2002
81
33

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.
Milim Kim, Hyun Jeong Kim, Yul Ri Chung, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park. J Breast Cancer 2018
24
33


Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
John F Forbes, Ivana Sestak, Anthony Howell, Bernardo Bonanni, Nigel Bundred, Christelle Levy, Gunter von Minckwitz, Wolfgang Eiermann, Patrick Neven, Michael Stierer,[...]. Lancet 2016
95
33

Microinvasive carcinoma of the breast.
Simonetta Bianchi, Vania Vezzosi. Pathol Oncol Res 2008
53
33


Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
99
33

Sonographic Features of Ductal Carcinoma In Situ of the Breast With Microinvasion: Correlation With Clinicopathologic Findings and Biomarkers.
Jie-Jie Yao, Wei-Wei Zhan, Man Chen, Xiao-Xiao Zhang, Ying Zhu, Xiao-Chun Fei, Xiao-Song Chen. J Ultrasound Med 2015
9
33

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Rahul R Parikh, Bruce G Haffty, Donald Lannin, Meena S Moran. Int J Radiat Oncol Biol Phys 2012
52
33

Revision of the American Joint Committee on Cancer staging system for breast cancer.
S Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W Bassett, Donald Berry, Kirby I Bland, Patrick I Borgen, Gary Clark, Stephen B Edge, Daniel F Hayes,[...]. J Clin Oncol 2002
830
33

DCIS with Microinvasion: Is It In Situ or Invasive Disease?
Cosette D Champion, Yi Ren, Samantha M Thomas, Oluwadamilola M Fayanju, Laura H Rosenberger, Rachel A Greenup, Carolyn S Menendez, E Shelley Hwang, Jennifer K Plichta. Ann Surg Oncol 2019
21
33

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
219
33

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
403
33

APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Changyin Feng, Qiaoling Zheng, Yinghong Yang, Meifang Xu, Yuane Lian, Jianping Huang, Yiting Jiang. Appl Immunohistochem Mol Morphol 2019
3
33

Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
Meghan R Flanagan, Michelle Stempel, Edi Brogi, Monica Morrow, Hiram S Cody. Ann Surg Oncol 2019
8
16

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
16

Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
Maíra Teixeira Dória, Jonathan Yugo Maesaka, Raymundo Soares de Azevedo Neto, Nestor de Barros, Edmund Chada Baracat, José Roberto Filassi. Clin Breast Cancer 2018
15
16

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
16

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.
Yasuhiro Okumura, Yutaka Yamamoto, Zhenhuan Zhang, Tatsuya Toyama, Teru Kawasoe, Mutsuko Ibusuki, Yumi Honda, Ken-ichi Iyama, Hiroko Yamashita, Hirotaka Iwase. BMC Cancer 2008
23
16

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Marie Beguinot, Marie-Melanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouedec, Lucie Tixier, Christophe Pomel, Frederique Penault-Llorca, Nina Radosevic-Robin. BMC Cancer 2018
31
16

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.
Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K Darcy, Mark J Smyth, Sherene Loi. Nat Rev Clin Oncol 2016
466
16

Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
Serena Bertozzi, Carla Cedolini, Ambrogio P Londero, Barbara Baita, Francesco Giacomuzzi, Decio Capobianco, Marta Tortelli, Alessandro Uzzau, Laura Mariuzzi, Andrea Risaliti. Medicine (Baltimore) 2019
9
16

A US Registry-Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast Cancer.
Benjamin M Parsons, Dipesh Uprety, Angela L Smith, Andrew J Borgert, Leah L Dietrich. J Natl Compr Canc Netw 2018
6
16

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Christine Tunon-de-Lara, Marie Pierre Chauvet, Marie Christine Baranzelli, Marc Baron, Jean Piquenot, Guillaume Le-Bouédec, Fréderique Penault-Llorca, Jean-Rémi Garbay, Jérôme Blanchot, Joëlle Mollard,[...]. Ann Surg Oncol 2015
20
16

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Yan Fang, Jiayi Wu, Wei Wang, Xiaochun Fei, Yu Zong, Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li,[...]. Oncotarget 2016
20
16

The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era.
Richard J Gray, Bryan Mulheron, Barbara A Pockaj, Amy Degnim, Stephen L Smith. Am J Surg 2007
16
16

Factors predicting microinvasion in Ductal Carcinoma in situ.
Sibel Ozkan-Gurdal, Neslihan Cabioglu, Beyza Ozcinar, Mahmut Muslumanoglu, Vahit Ozmen, Mustafa Kecer, Ekrem Yavuz, Abdullah Igci. Asian Pac J Cancer Prev 2014
32
16

Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Cindy B Matsen, Allison Hirsch, Anne Eaton, Michelle Stempel, Alexandra Heerdt, Kimberly J Van Zee, Hiram S Cody, Monica Morrow, George Plitas. Ann Surg Oncol 2014
28
16

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Paul L Nguyen, Alphonse G Taghian, Matthew S Katz, Andrzej Niemierko, Rita F Abi Raad, Whitney L Boon, Jennifer R Bellon, Julia S Wong, Barbara L Smith, Jay R Harris. J Clin Oncol 2008
590
16

Management of small T1a/b breast cancer by tumor subtype.
Tanja Ignatov, Holm Eggemann, Elke Burger, Serban Dan Costa, Atanas Ignatov. Breast Cancer Res Treat 2017
18
16

Multifocal and multicentric breast cancer: does each focus matter?
Nathan J Coombs, John Boyages. J Clin Oncol 2005
128
16

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
Ines Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, Rizvan Mamet, Harold J Burstein, Stephen B Edge, Ana M Gonzalez-Angulo, Beverly Moy, Hope S Rugo, Richard L Theriault,[...]. J Clin Oncol 2014
164
16

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
31
16

Axillary node staging for microinvasive breast cancer: is it justified?
John M Lyons, Michelle Stempel, Kimberly J Van Zee, Hiram S Cody. Ann Surg Oncol 2012
26
16

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Jing Si, Benlong Yang, Rong Guo, Naisi Huang, Chenlian Quan, Linxiaoxi Ma, Bingqiu Xiu, Yun Cao, Yue Tang, Linxiao Shen,[...]. Cancer Biol Med 2019
6
16

Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.
Mary C Schroeder, Charles F Lynch, Taher Abu-Hejleh, Elizabeth A Chrischilles, Alexandra Thomas. Clin Breast Cancer 2015
12
16

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, Marie Overgaard, Hanne Melgaard Nielsen, Jens Overgaard. J Clin Oncol 2008
410
16

Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.
Giorgio Zavagno, Valentina Belardinelli, Renato Marconato, Paolo Carcoforo, Zeno Franchini, Giuliano Scalco, Paolo Burelli, Paolo Pietrarota, Roberto Mencarelli, Giorgia Marconato,[...]. Breast 2007
36
16

Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
José Luiz B Bevilacqua, Michael W Kattan, Jane V Fey, Hiram S Cody, Patrick I Borgen, Kimberly J Van Zee. J Clin Oncol 2007
198
16


Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Yusuke Watanabe, Keisei Anan, Michiyo Saimura, Kenichiro Koga, Minoru Fujino, Mari Mine, Sadafumi Tamiya, Kazuyoshi Nishihara, Toru Nakano, Shoshu Mitsuyama. Breast Cancer 2018
13
16

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
Elsebeth Lynge, Antonio Ponti, Ted James, Ondřej Májek, My von Euler-Chelpin, Ahti Anttila, Patricia Fitzpatrick, Alfonso Frigerio, Masaaki Kawai, Astrid Scharpantgen,[...]. Eur J Cancer 2014
35
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.